The MDM2 antagonist nutlin-3 is lethal to mantle cell lymphoma with wild type p53

被引:1
|
作者
Tabe, Yoko [1 ]
Szbasigari, Denise [1 ]
Rudelius, Martina [1 ]
Pittaluga, Stefania [1 ]
Raffel, Mark [1 ]
机构
[1] Natl Canc Inst, Pathol Lab, Bethesda, MD USA
关键词
D O I
10.1182/blood.V110.11.1382.1382
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1382
引用
收藏
页码:415A / 415A
页数:1
相关论文
共 50 条
  • [1] Nutlin-3, an Antagonist of MDM2, Enhances the Radiosensitivity of Esophageal Squamous Cancer with Wild-Type p53
    He, Tianli
    Guo, Jiayou
    Song, Hongmei
    Zhu, Hongcheng
    Di, Xiaoke
    Min, Hua
    Wang, Yuandong
    Chen, Guangzong
    Dai, Wangshu
    Ma, Jianhua
    Sun, Xinchen
    Ma, Jianxin
    [J]. PATHOLOGY & ONCOLOGY RESEARCH, 2018, 24 (01) : 75 - 81
  • [2] Antitumor Activity of the Selective MDM2 Antagonist Nutlin-3 Against Chemoresistant Neuroblastoma With Wild-Type p53
    Van Maerken, Tom
    Ferdinande, Liesbeth
    Taildeman, Jasmien
    Lambertz, Irina
    Yigit, Nurten
    Vercruysse, Liesbeth
    Rihani, Ali
    Michaelis, Martin
    Cinatl, Jindrich, Jr.
    Cuvelier, Claude A.
    Marine, Jean-Christophe
    De Paepe, Anne
    Bracke, Marc
    Speleman, Frank
    Vandesompele, Jo
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (22) : 1562 - 1574
  • [3] MDM2 Antagonist Nutlin-3 Displays Antiproliferative and Proapoptotic Activity in Mantle Cell Lymphoma
    Tabe, Yoko
    Sebasigari, Denise
    Jin, Linhua
    Rudelius, Martina
    Davies-Hill, Theresa
    Miyake, Kazunori
    Miida, Takashi
    Pittaluga, Stefania
    Raffeld, Mark
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (03) : 933 - 942
  • [4] p53 mutations induced by the MDM2 inhibitor nutlin-3 in p53 wild-type neuroblastoma cells
    Michaelis, M.
    Wass, M.
    Cinatl, J.
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 69 : S72 - S72
  • [5] The MDM2 antagonist nutlin-3 is a potent inducer of apoptosis in pediatric acute lymphoblastic leukemia cells with wild-type p53 and overexpression of MDM2
    Gu, Lubing
    Zhu, Ningxi
    Findley, Harry W.
    Zhou, Muxiang
    [J]. BLOOD, 2007, 110 (11) : 137B - 137B
  • [6] MDM2 antagonist nutlin-3 is a potent inducer of apoptosis in pediatric acute lymphoblastic leukemia cells with wild-type p53 and overexpression of MDM2
    Gu, L.
    Zhu, N.
    Findley, H. W.
    Zhou, M.
    [J]. LEUKEMIA, 2008, 22 (04) : 730 - 739
  • [7] MDM2 antagonist nutlin-3 is a potent inducer of apoptosis in pediatric acute lymphoblastic leukemia cells with wild-type p53 and overexpression of MDM2
    L Gu
    N Zhu
    H W Findley
    M Zhou
    [J]. Leukemia, 2008, 22 : 730 - 739
  • [8] Mdm2 antagonist Nutlin-3 induces apoptosis in p53 mutant human colon carcinoma cells
    Bhattacharya, Sujoy
    Ray, Ramesh M.
    Johnson, Leonard R.
    [J]. FASEB JOURNAL, 2009, 23
  • [9] Reduced transcriptional activity in the p53 pathway of senescent cells revealed by the MDM2 antagonist nutlin-3
    Huang, Baoying
    Vassilev, Lyubomir T.
    [J]. AGING-US, 2009, 1 (10): : 845 - 854
  • [10] How Nutlin-3 disrupts the MDM2–p53 interaction: a theoretical investigation
    Shah Md. Abdur Rauf
    Hiromitsu Takaba
    Carlos A. Del Carpio
    Akira Miyamoto
    [J]. Medicinal Chemistry Research, 2014, 23 : 1998 - 2006